How to Import Herbal Medicine to USA: FDA Compliance Guide

Importing herbal medicine into the United States demands precise regulatory navigation because the FDA classifies every product as a dietary supplement, drug, or conventional food before it ever reaches a port. A single misstep in classification, facility registration, or labeling triggers detention, costly relabeling, or outright refusal that can destroy a shipment's commercial value. This guide walks through the complete compliance workflow from choosing the correct import pathway through ingredient legality screening, Prior Notice filing, and post-entry obligations. You will learn how to distinguish personal use from commercial distribution, verify foreign facility registrations and DUNS numbers, structure Supplement Facts panels that meet 21 CFR 101 and 111, and screen every ingredient against FDA Import Alerts and DEA schedules before the supplier books the vessel.

Determine Your Import Pathway: Personal Use vs Commercial Distribution

Choosing the correct import pathway is the first compliance decision an importer makes because the regulatory burden differs entirely between personal use and commercial distribution. The FDA exercises enforcement discretion for personal importation under specific conditions while commercial shipments trigger full facility registration prior notice and FSVP obligations. Misclassifying a commercial shipment as personal use exposes the importer to detention refusal and potential penalties. According to Trendeconomy (UN Comtrade data) US imports of HS 1211 plants used in pharmacy were $544 million in 2022 and fell 6.22% in value in 2023 compared with 2022 reflecting shifting trade volumes that customs scrutinizes closely. Mexico supplied a 10.6% share worth 54 million US$ of US HS 1211 medicinal and pharmacy plant imports in 2023 according to Trendeconomy (UN Comtrade data).

Personal Importation Policy criteria and 90-day supply limit

The FDA Personal Importation Policy allows entry of herbal medicine for personal use only when the product is not for resale the quantity does not exceed a 90-day supply and the product does not present an unreasonable risk. The importer must affirm in writing that the product is for their own treatment or that of a family member and provide the name and address of the US licensed physician overseeing the treatment if the product is a drug. Customs and Border Protection officers verify the quantity against the labeled dosage to confirm the 90-day threshold. Shipments exceeding this limit or lacking a physician letter for drug products are treated as commercial entries requiring full compliance.

Commercial distribution triggers and Importer of Record obligations

Any shipment intended for sale resale distribution to third parties or business inventory constitutes commercial distribution. The Importer of Record must obtain a Customs bond secure a DUNS number register the foreign facility with FDA and file Prior Notice before arrival. The importer assumes full FSVP responsibility including supplier verification hazard analysis and corrective action documentation. Commercial entries also require accurate HTS classification FDA product codes and compliance with labeling requirements under 21 CFR 101 and 111. Failure to meet these obligations results in detention at the port of entry.

Enforcement risks of misclassifying commercial goods as personal

Declaring commercial goods as personal use to avoid regulatory requirements is a violation of 18 USC 542 and 19 USC 1592. CBP uses shipment frequency value consignee patterns and marketing evidence such as website listings or invoices to identify commercial intent. Penalties include seizure of goods civil fines up to the domestic value of the merchandise and criminal prosecution for fraud. Repeat violations lead to heightened scrutiny on future shipments and potential placement on the FDA Import Alert list. Importers should maintain clear records demonstrating the genuine nature of each shipment to defend against misclassification allegations.

Factor	Personal Use	Commercial Distribution
Quantity Limit	90-day supply	No limit (commercial quantities)
Intent	Personal treatment only	Resale distribution or business inventory
FDA Facility Registration	Not required	Mandatory for foreign manufacturer
Prior Notice	Not required	Mandatory before arrival
FSVP Compliance	Not applicable	Full program required
Labeling Requirements	Minimal (identity quantity)	Full 21 CFR 101 111 DSHEA
Customs Bond	Not required	Required (continuous or single entry)
Importer of Record	Individual patient	Registered business entity

The table above contrasts the two pathways across eight critical compliance dimensions. Personal use offers a narrow exemption for genuine patients while commercial distribution demands a complete regulatory infrastructure. Importers evaluating shipment size frequency and business model should map each factor to their operation to confirm the correct pathway before shipping.

Classify Your Herbal Product: FDA Regulatory Category Decision Tree

FDA classification determines every subsequent compliance step because dietary supplements drugs and conventional foods follow distinct regulatory frameworks. The agency evaluates intended use as expressed through labeling claims marketing materials and product composition. A product marketed to diagnose treat cure or prevent disease is a drug regardless of its herbal origin. Products labeled for nutritional support with structure function claims fall under dietary supplement regulations provided they meet DSHEA definitions. According to Trendeconomy (UN Comtrade data) US imports of commodity group 1211 (plants and parts of plants used primarily in perfumery, pharmacy or for insecticidal and similar purposes) totalled $510 million in 2023 underscoring the commercial scale of botanical trade that requires precise classification. India was the largest supplier of HS 1211 medicinal and pharmacy plants to the US in 2023 with a 31% share worth 161 million US$ according to Trendeconomy (UN Comtrade data).

Dietary supplement vs drug classification factors

The primary distinction rests on intended use. Dietary supplements support structure or function of the body without claiming to treat disease. Drugs are articles intended for use in the diagnosis cure mitigation treatment or prevention of disease. The FDA examines product names labeling claims website content and advertising to determine intent. An herbal product labeled "supports immune health" is a supplement while "treats viral infections" makes it an unapproved new drug. Importers must audit all promotional materials before entry to ensure claims align with the desired regulatory category.

New Dietary Ingredient (NDI) notification triggers

An NDI notification is required when a dietary ingredient was not marketed in the United States before October 15 1994 and has not been present in the food supply as an article used for food without chemical alteration. The manufacturer or distributor must submit a premarket notification to FDA at least 75 days before marketing containing evidence of safety. Herbal extracts standardized to specific marker compounds often qualify as NDIs even if the botanical source has a history of use. Failure to file results in the product being deemed adulterated under 21 USC 342(f). Importers should verify NDI status with their foreign supplier before committing to purchase orders.

Conventional food classification for herbal teas and spices

Herbal products sold as teas spices or culinary ingredients may qualify as conventional foods if they are represented for taste aroma or nutritive value rather than therapeutic benefit. The labeling must comply with 21 CFR 101 including nutrition facts ingredient declaration and allergen labeling. Structure function claims are not permitted on conventional foods. However if the same botanical is marketed as a tea for "relaxation" or "digestive support" it crosses into supplement or drug territory. Importers should align product formulation labeling and marketing consistently to maintain the intended classification throughout the supply chain.

Classification	Primary Statute	Premarket Requirement	Claim Type Permitted	GMP Standard	Adverse Event Reporting
Dietary Supplement	DSHEA 1994	NDI notification if new ingredient	Structure function only	21 CFR 111	Mandatory serious AER
Drug (OTC or Rx)	FD&C Act	NDA ANDA or OTC Monograph	Therapeutic claims allowed	21 CFR 211	Mandatory FAERS
Conventional Food	FD&C Act	GRAS or Food Additive Petition	Nutrient content health claims only	21 CFR 117	Voluntary CAERS

The decision tree table maps three regulatory categories to their governing statutes premarket hurdles permitted claims GMP standards and adverse event obligations. Dietary supplements occupy a middle ground with NDI notifications and structure function claims while drugs demand full premarket approval and foods restrict claims to nutrition. Importers should use this matrix to validate that their product formulation labeling and supplier documentation align with a single consistent category before filing entry.

Pre-Import Compliance Checklist: Manufacturer & Product Requirements

Manufacturer registrations and product documents required before shipping herbal medicine to the USA include a valid FDA facility registration, a DUNS number for the foreign site, a Certificate of Analysis for each lot, and current GMP certification. These items form the documentary backbone that CBP and FDA review during entry review and inspection. Missing or expired documents trigger automatic detention under Import Alert 99-32 or 54-15. Importers must verify every element before the supplier books the vessel or flight.

FDA facility registration and renewal deadlines

FDA facility registration and renewal deadlines require foreign manufacturers to register annually between October 1 and December 31. The registration must be renewed every even-numbered year regardless of shipment frequency. A facility that fails to renew by December 31 is removed from the FDA database and any subsequent shipment will be refused admission. The registration number must appear on the Prior Notice submission and the commercial invoice. Importers should confirm the registration status in the FDA FURLS database before each purchase order.

DUNS number acquisition for foreign sites

DUNS number acquisition for foreign sites is mandatory for FDA facility registration since 2020. The manufacturer must request a DUNS number from Dun & Bradstreet directly or through a local agent. The process typically takes five to ten business days and requires the legal entity name, physical address, and ownership details. The DUNS number must match the facility address exactly as it appears on the FDA registration. A mismatch between the DUNS record and the FDA registration causes Prior Notice rejection and entry delays.

Certificate of Analysis and GMP certification requirements

Certificate of Analysis and GMP certification requirements apply to every lot of herbal material entering the USA. The CoA must identify the botanical species, plant part, extraction solvent, marker compound assay results, heavy metals, pesticide residues, and microbial limits. GMP certification must align with 21 CFR 111 for dietary supplements or 21 CFR 117 for food ingredients. Third-party certificates from NSF, USP, or ISO 22000 auditors are accepted if the audit scope covers the specific production line. Expired certificates or those covering only the raw herb but not the finished extract will not satisfy FDA reviewers.

Document	Issuing Body	Validity Period	Required For Entry	Common Deficiency
FDA Facility Registration	FDA FURLS	Biennial (even years)	Yes	Expired renewal
DUNS Number	Dun & Bradstreet	Permanent	Yes	Address mismatch
Certificate of Analysis	Manufacturer / Third-party Lab	Per Lot	Yes	Missing marker compounds
GMP Certification	NSF, USP, ISO 22000 Auditor	Annual Surveillance	Yes	Scope excludes extract line

The table above maps each mandatory document to its issuing authority, validity window, and the most frequent deficiency that causes FDA holds. Importers should audit this checklist quarterly and require suppliers to upload updated files to a shared drive before production begins. A single expired registration can delay an entire container for weeks while the manufacturer completes renewal.

Facility Registration, DUNS & Prior Notice: The Mandatory Filings

Filing FDA Prior Notice and registering a foreign facility for herbal supplement imports requires a three-step sequence: obtain a DUNS number, register the facility in FDA FURLS, and submit Prior Notice through the PNSI system before the shipment departs. Each step has hard deadlines that cannot be waived. The Prior Notice confirmation number must be transmitted to the customs broker for ACE entry filing. Errors in any field will generate a "May Proceed" hold or a full refusal at the port of entry.

PNSI account setup and submission timelines by shipment mode

PNSI account setup and submission timelines by shipment mode dictate that Prior Notice must be filed no later than two hours before arrival for road shipments, four hours for air, and eight hours for ocean vessels. The importer or their customs broker creates a PNSI account using the FDA Industry Systems portal. The submission requires the facility registration number, DUNS number, product description, quantity, anticipated arrival information, and the entry type code. Late submissions are accepted but flag the entry for intensive examination. Importers should file Prior Notice as soon as the bill of lading or air waybill is issued.

Prior Notice confirmation numbers and CBP linkage

Prior Notice confirmation numbers and CBP linkage operate through the Automated Commercial Environment. The PNSI system generates a unique Prior Notice Confirmation (PNC) number that the customs broker enters on the ACE entry manifest. CBP automatically matches the PNC to the entry line. If the PNC is missing or does not match the product description on the commercial invoice, CBP issues a document request or places the shipment on hold. The importer of record must ensure the broker receives the PNC before the vessel arrives at the first US port.

Common filing errors causing automatic holds

Common filing errors causing automatic holds include mismatched facility registration numbers, incorrect HTS codes that do not align with the FDA product code, missing DUNS numbers, and inaccurate anticipated arrival dates. The PNSI system validates the facility registration status in real time; a lapsed registration rejects the submission immediately. Importers should run a test filing for new products or new suppliers before the first commercial shipment. Using a checklist that cross-references the commercial invoice, packing list, and Prior Notice data eliminates 90 percent of preventable holds.

Labeling & Claims Compliance: 21 CFR 101, 111 & DSHEA Requirements

The FDA requires every herbal supplement label to display a Supplement Facts panel, an ingredient list, the net quantity of contents, the name and place of business of the manufacturer packer or distributor, and a country of origin statement. These elements must follow 21 CFR 101 formatting rules for type size prominence and language. Noncompliant labels trigger detention at the border and may require costly relabeling under customs supervision before release.

Supplement Facts panel and ingredient list formatting

The Supplement Facts panel must list each dietary ingredient by common or usual name with the quantitative amount per serving and the percent daily value where established. Proprietary blends declare the total weight of the blend and the ingredients in descending order of predominance without individual amounts. The ingredient list below the panel includes non-dietary ingredients such as fillers binders and flavors by common name. Type size must be at least 6 point for the panel and 4.5 point for the ingredient list with sufficient contrast against the background. Serving size must reflect the amount customarily consumed and use metric units with US customary units in parentheses.

Structure/function claim notification and disclaimer requirements

Structure function claims describe the role of an ingredient in maintaining normal structure or function of the body and must be truthful and not misleading. The label must bear the mandatory disclaimer: "This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose treat cure or prevent any disease." The notification with the text of the claim must be submitted to the FDA within 30 days of first marketing the product in the United States. Disease claims such as "treats arthritis" or "lowers blood pressure" convert the product into an unapproved new drug and are prohibited without an approved new drug application.

Country of origin and distributor address mandates

Country of origin must appear legibly and conspicuously on the label in English. For herbal supplements the country of origin is the country where the product was substantially transformed which is typically where the final encapsulation bottling and labeling occurred. The name and place of business of the manufacturer packer or distributor must include the street address city state and zip code unless the entity is listed in a current city or telephone directory. A domestic address satisfies the requirement even if the product is manufactured abroad. Missing or incomplete address information is a common cause of FDA detention under 21 CFR 101.5.

Ingredient Legality Screening: Import Alerts, NDI Status & Controlled Substances

Before shipping any herbal product to the United States the importer must verify that every ingredient is legally marketable. The FDA maintains Import Alerts that authorize detention without physical examination for specific ingredients or manufacturers. The DEA schedules controlled substances that require registration and quotas. The New Dietary Ingredient master list identifies ingredients that require a pre-market safety notification. Screening all three sources prevents costly refusals and potential criminal liability.

FDA Import Alert 99-32 and 54-15 red-flag ingredients

Import Alert 99-32 targets products containing active pharmaceutical ingredients or undeclared drug substances often found in weight loss sexual enhancement and bodybuilding supplements. Import Alert 54-15 covers specific herbal ingredients such as aristolochic acid comfrey kava and germanium that present safety risks. The FDA updates these alerts regularly and detention occurs at the port of entry without prior notice. Importers should search the FDA Import Alert database by ingredient name and manufacturer name before each shipment. A match on either the ingredient or the foreign facility triggers automatic detention and requires a petition with laboratory evidence to secure release.

DEA controlled substance check for kratom ephedra and CBD

The DEA schedules substances under the Controlled Substances Act based on abuse potential and medical use. Ephedra alkaloids are Schedule I and their importation is prohibited except under a DEA research registration. Kratom mitragynine and 7-hydroxymitragynine are not federally scheduled but the FDA has issued import alerts and several states ban possession. CBD derived from hemp with less than 0.3 percent THC is not a controlled substance but the FDA prohibits its addition to food or dietary supplements. Importers must confirm the THC concentration with a certificate of analysis from an ISO 17025 accredited lab and verify state legality for the destination market.

NDI master list verification for post-1994 ingredients

The New Dietary Ingredient notification requirement applies to any dietary ingredient not marketed in the United States before October 15 1994. The FDA maintains a public list of submitted NDI notifications with the agency's response letter. An ingredient with a "no objection" letter may be marketed lawfully. An ingredient with an "inadequate" letter or no notification on file cannot be legally sold as a dietary supplement. The importer must obtain the NDI notification number and the FDA response letter from the supplier and confirm the ingredient identity matches the notification exactly including the plant part extraction method and specification.

Screening Source	Scope	Key Action	Consequence of Match
FDA Import Alert 99-32	Undeclared drug ingredients	Search by ingredient and manufacturer	Detention without physical examination
FDA Import Alert 54-15	Specific toxic herbs	Search by ingredient name	Automatic detention
DEA Schedules I-V	Controlled substances	Verify scheduling status and THC %	Seizure and criminal referral
NDI Notification Inventory	Post-1994 dietary ingredients	Confirm "no objection" letter on file	Product deemed adulterated

The table above maps each screening source to its scope and the immediate regulatory consequence of a positive match. Import Alerts act at the border with detention authority while DEA scheduling triggers seizure and potential criminal investigation. NDI status determines whether the product is adulterated under the FD&C Act before it ever reaches the port. Importers should run all four checks in sequence for every new formulation and repeat the Import Alert check for every shipment because the FDA adds firms and products weekly.

Conclusion

Importing herbal medicine into the United States requires locking in the correct regulatory pathway before the supplier books the vessel. Verify that the foreign facility holds a current FDA registration with a matching DUNS number, confirm ingredient legality against Import Alerts and DEA schedules, and ensure every lot carries a Certificate of Analysis covering identity, heavy metals, pesticides, and microbial limits. File Prior Notice within the required window for the mode of transport, and maintain FSVP documentation that proves supplier verification and hazard analysis are complete. Misclassifying commercial goods as personal use invites seizure and penalties under 18 USC 542 and 19 USC 1592.

Align labeling, claims, and GMP certification to a single FDA category, dietary supplement, drug, or conventional food, before the shipment departs. If you need to locate compliant suppliers or review shipment histories for specific botanicals, start your search at Global Trade Plaza.

Further guides: Exporting Pakistani Khadi Fabric to Europe: Markets, Buyers and Compliance, Importing into the United States: Process and Compliance.

Frequently Asked Questions

Can I send herbal medicine to USA for personal use?

Yes, the FDA Personal Importation Policy allows entry for personal treatment with a 90-day supply limit. The product must not be for resale and must not present an unreasonable risk. A physician letter is required if the product is classified as a drug.

Can you import medicine into the US without FDA approval?

Personal use imports do not require FDA approval if they meet the 90-day supply and physician letter criteria. Commercial imports of herbal products classified as drugs require NDA, ANDA, or OTC monograph approval before entry. Dietary supplements require facility registration and NDI notification if applicable.

How to import herbal medicine to USA from China?

Verify the Chinese manufacturer holds a valid FDA facility registration and matching DUNS number. File Prior Notice via PNSI 8 hours before ocean arrival or 4 hours before air arrival. Ensure each lot has a Certificate of Analysis and screen ingredients against Import Alerts 99-32 and 54-15.

How to import herbal medicine to USA from Europe?

Confirm the European facility is registered with FDA and holds a DUNS number matching the registration address. Submit Prior Notice within the required timeframe based on transport mode. Obtain a Certificate of Analysis for each lot and verify no ingredients appear on FDA Import Alerts or DEA schedules.

How to import herbal medicine to USA from Germany?

Follow the same commercial pathway as other EU origins: validate FDA facility registration, DUNS alignment, and Prior Notice filing. German manufacturers often hold ISO or GMP certifications that support 21 CFR 111 compliance but do not replace FDA requirements. Screen for novel food restrictions that may affect ingredient eligibility.

Can I bring herbal medicine to USA in my luggage?

Yes, accompanied baggage falls under the Personal Importation Policy with the same 90-day supply limit and physician letter requirement for drug products. Declare all medications on the CBP Form 6059B. Officers will verify quantity against labeled dosage and may refuse entry for undeclared or excessive amounts.

What documents are required to import herbal medicine to USA?

Commercial imports require FDA facility registration number, DUNS number, Prior Notice confirmation, Customs bond, commercial invoice, packing list, and Certificate of Analysis per lot. Dietary supplements need Supplement Facts panels compliant with 21 CFR 101 and 111. Drugs require proof of NDA, ANDA, or OTC monograph compliance.

How to import herbal medicine to USA documents from China?

Chinese suppliers must provide a Certificate of Analysis identifying botanical species, plant part, marker compounds, heavy metals, pesticides, and microbial limits. Include a manufacturer declaration of GMP compliance per 21 CFR 111. Translate all documents into English and ensure the facility registration and DUNS number appear on the commercial invoice.

How to import herbal medicine to USA documents from Germany?

German exporters should supply a Certificate of Analysis meeting FDA specifications and a GMP certificate aligned with 21 CFR 111. Provide the FDA facility registration number and DUNS number on the commercial invoice. EU organic or pharmacopeia certificates support quality claims but do not substitute for FDA-required lot-specific analysis.

How to import herbal medicine to USA costs and fees?

Costs include Customs bond premiums (typically $500, $1,000 annually for continuous bonds), customs broker fees ($100, $300 per entry), and FDA Prior Notice filing (free via PNSI). Laboratory testing for Certificate of Analysis ranges $300, $1,500 per lot. FSVP development and supplier verification add $2,000, $10,000 initially.

What is the FDA Prior Notice requirement for herbal supplements?

Prior Notice must be filed electronically via the PNSI system before arrival: 2 hours for road, 4 hours for air, and 8 hours for ocean shipments. The submission requires the FDA facility registration number, DUNS number, product description, quantity, and entry location. Failure to file results in refusal of admission and detention at the port.

What herbal ingredients are banned from import to USA?

Ingredients subject to Import Alert 54-15 include aristolochic acid, kava, comfrey, chaparral, and germander due to safety risks. Import Alert 99-32 targets products with undeclared drug ingredients such as sibutramine or PDE-5 inhibitors. DEA Schedule I botanicals like marijuana and khat are prohibited. Screen every ingredient against current alerts before shipping.